An overview of key immunotherapy concepts and recent advances in oncology, with emphasis on clinical application in solid tumors and hematologic malignancies, as well as evidence-based strategies for toxicity recognition and management

This on demand provides a state-of-the-art update on complex management scenarios in hemostasis and thrombosis, including stroke in cancer, cardiac thrombosis, and thrombotic risk in acute lymphoblastic leukemia (ALL).

This on demand provides a state-of-the-art update on advances in the management of hemolytic anemias, with a focus on therapeutic strategies for hereditary anemias, paroxysmal nocturnal hemoglobinuria (PNH), cold agglutinin disease, and other complement-mediated hemolytic disorders.

This on demand provides a state-of-the-art update on hematologic toxicities and thrombotic complications associated with cellular therapies and cancer immunotherapies.

Journal of Experimental Medicine (JEM) offers the opportunity to earn CME credit through a joint providership with MSK CME. Choose from multiple JEM articles, read and reflect on the content, and complete assessment questions to claim credit.